IP Verse
Top Law Firms
Unified Patent Court
Trending Technologies
Blogs
Contact Us
Toggle menu
Glenmark Pharmaceuticals Europe Ltd. opposition analysis
COMPANY ANALYSIS
Latest oppositions filed by Glenmark Pharmaceuticals Europe Ltd.
Patent Number:
EP2959894
Title:
S1P Receptor Modulators For Treating Multiple Sclerosis
Applicant:
NOVARTIS AG
Opposition Date:
Oct 12, 2022
Latest oppositions filed by Glenmark Pharmaceuticals Europe Ltd.
Patent Number
Title
Applicant
Opposition Date
EP2959894
S1P Receptor Modulators For Treating Multiple Sclerosis
NOVARTIS AG
Oct 12, 2022
Competitors of Glenmark Pharmaceuticals Europe Ltd.
NOVARTIS AG
Want to track Glenmark Pharmaceuticals Europe Ltd.?
Feel free to send us a message here and we will get back to you
Name
Email
Message
Let's get in touch